The global market for Mycoplasma Diagnostics was valued at US$ 801 million in the year 2024 and is projected to reach a revised size of US$ 1122 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Mycoplasma Diagnostics Market

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.

Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

This report aims to provide a comprehensive presentation of the global market for Mycoplasma Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Diagnostics.

The Mycoplasma Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mycoplasma Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mycoplasma Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mycoplasma Diagnostics Market Report

Report Metric	Details
Report Name	Mycoplasma Diagnostics Market
Accounted market size in year	US$ 801 million
Forecasted market size in 2031	US$ 1122 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Kits & Reagents Instruments Software & Services
Segment by Application	Hospitals Diagnostic Laboratories Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics, Tecan Trading (Tecan Group), Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Mycoplasma Diagnostics Market growing?

Ans: The Mycoplasma Diagnostics Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Mycoplasma Diagnostics Market size in 2031?

Ans: The Mycoplasma Diagnostics Market size in 2031 will be US$ 1122 million.

Who are the main players in the Mycoplasma Diagnostics Market report?

Ans: The main players in the Mycoplasma Diagnostics Market are Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics, Tecan Trading (Tecan Group), Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche

What are the Application segmentation covered in the Mycoplasma Diagnostics Market report?

Ans: The Applications covered in the Mycoplasma Diagnostics Market report are Hospitals, Diagnostic Laboratories, Clinics, Others

What are the Type segmentation covered in the Mycoplasma Diagnostics Market report?

Ans: The Types covered in the Mycoplasma Diagnostics Market report are Kits & Reagents, Instruments, Software & Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mycoplasma Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Kits & Reagents

1.2.3 Instruments

1.2.4 Software & Services

1.3 Market by Application

1.3.1 Global Mycoplasma Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Clinics

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mycoplasma Diagnostics Market Perspective (2020-2031)

2.2 Global Mycoplasma Diagnostics Growth Trends by Region

2.2.1 Global Mycoplasma Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Mycoplasma Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Mycoplasma Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Mycoplasma Diagnostics Market Dynamics

2.3.1 Mycoplasma Diagnostics Industry Trends

2.3.2 Mycoplasma Diagnostics Market Drivers

2.3.3 Mycoplasma Diagnostics Market Challenges

2.3.4 Mycoplasma Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mycoplasma Diagnostics Players by Revenue

3.1.1 Global Top Mycoplasma Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Mycoplasma Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Mycoplasma Diagnostics Revenue

3.4 Global Mycoplasma Diagnostics Market Concentration Ratio

3.4.1 Global Mycoplasma Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Diagnostics Revenue in 2024

3.5 Global Key Players of Mycoplasma Diagnostics Head office and Area Served

3.6 Global Key Players of Mycoplasma Diagnostics, Product and Application

3.7 Global Key Players of Mycoplasma Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Mycoplasma Diagnostics Breakdown Data by Type

4.1 Global Mycoplasma Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Mycoplasma Diagnostics Forecasted Market Size by Type (2026-2031)

5 Mycoplasma Diagnostics Breakdown Data by Application

5.1 Global Mycoplasma Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Mycoplasma Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Mycoplasma Diagnostics Market Size (2020-2031)

6.2 North America Mycoplasma Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Mycoplasma Diagnostics Market Size by Country (2020-2025)

6.4 North America Mycoplasma Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mycoplasma Diagnostics Market Size (2020-2031)

7.2 Europe Mycoplasma Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Mycoplasma Diagnostics Market Size by Country (2020-2025)

7.4 Europe Mycoplasma Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Mycoplasma Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Mycoplasma Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Mycoplasma Diagnostics Market Size (2020-2031)

9.2 Latin America Mycoplasma Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Mycoplasma Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Mycoplasma Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mycoplasma Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Mycoplasma Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Mycoplasma Diagnostics Introduction

11.1.4 Agilent Technologies Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.1.5 Agilent Technologies Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Introduction

11.2.4 Thermo Fisher Scientific Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 PromoCell

11.3.1 PromoCell Company Details

11.3.2 PromoCell Business Overview

11.3.3 PromoCell Mycoplasma Diagnostics Introduction

11.3.4 PromoCell Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.3.5 PromoCell Recent Development

11.4 Charles River Laboratories International

11.4.1 Charles River Laboratories International Company Details

11.4.2 Charles River Laboratories International Business Overview

11.4.3 Charles River Laboratories International Mycoplasma Diagnostics Introduction

11.4.4 Charles River Laboratories International Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.4.5 Charles River Laboratories International Recent Development

11.5 Merck KGaA

11.5.1 Merck KGaA Company Details

11.5.2 Merck KGaA Business Overview

11.5.3 Merck KGaA Mycoplasma Diagnostics Introduction

11.5.4 Merck KGaA Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.5.5 Merck KGaA Recent Development

11.6 Lonza Group

11.6.1 Lonza Group Company Details

11.6.2 Lonza Group Business Overview

11.6.3 Lonza Group Mycoplasma Diagnostics Introduction

11.6.4 Lonza Group Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.6.5 Lonza Group Recent Development

11.7 Takara Bio (Takara Holding Company.)

11.7.1 Takara Bio (Takara Holding Company.) Company Details

11.7.2 Takara Bio (Takara Holding Company.) Business Overview

11.7.3 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Introduction

11.7.4 Takara Bio (Takara Holding Company.) Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.7.5 Takara Bio (Takara Holding Company.) Recent Development

11.8 Savyon Diagnostics

11.8.1 Savyon Diagnostics Company Details

11.8.2 Savyon Diagnostics Business Overview

11.8.3 Savyon Diagnostics Mycoplasma Diagnostics Introduction

11.8.4 Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.8.5 Savyon Diagnostics Recent Development

11.9 Tecan Trading (Tecan Group)

11.9.1 Tecan Trading (Tecan Group) Company Details

11.9.2 Tecan Trading (Tecan Group) Business Overview

11.9.3 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Introduction

11.9.4 Tecan Trading (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.9.5 Tecan Trading (Tecan Group) Recent Development

11.10 Sartorius Stedim BioOutsource

11.10.1 Sartorius Stedim BioOutsource Company Details

11.10.2 Sartorius Stedim BioOutsource Business Overview

11.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Introduction

11.10.4 Sartorius Stedim BioOutsource Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.10.5 Sartorius Stedim BioOutsource Recent Development

11.11 American Type Culture Collection (ATCC)

11.11.1 American Type Culture Collection (ATCC) Company Details

11.11.2 American Type Culture Collection (ATCC) Business Overview

11.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Introduction

11.11.4 American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.11.5 American Type Culture Collection (ATCC) Recent Development

11.12 F Hoffmann-La Roche

11.12.1 F Hoffmann-La Roche Company Details

11.12.2 F Hoffmann-La Roche Business Overview

11.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Introduction

11.12.4 F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2020-2025)

11.12.5 F Hoffmann-La Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent Technologies

Thermo Fisher Scientific

PromoCell

Charles River Laboratories International

Merck KGaA

Lonza Group

Takara Bio (Takara Holding Company.)

Savyon Diagnostics

Tecan Trading (Tecan Group)

Sartorius Stedim BioOutsource

American Type Culture Collection (ATCC)

F.Hoffmann-La Roche

List of Tables

Table 1. Global Mycoplasma Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Kits & Reagents

Table 3. Key Players of Instruments

Table 4. Key Players of Software & Services

Table 5. Global Mycoplasma Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Mycoplasma Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Mycoplasma Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Mycoplasma Diagnostics Market Share by Region (2020-2025)

Table 9. Global Mycoplasma Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Mycoplasma Diagnostics Market Share by Region (2026-2031)

Table 11. Mycoplasma Diagnostics Market Trends

Table 12. Mycoplasma Diagnostics Market Drivers

Table 13. Mycoplasma Diagnostics Market Challenges

Table 14. Mycoplasma Diagnostics Market Restraints

Table 15. Global Mycoplasma Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Mycoplasma Diagnostics Market Share by Players (2020-2025)

Table 17. Global Top Mycoplasma Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Diagnostics as of 2024)

Table 18. Ranking of Global Top Mycoplasma Diagnostics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Mycoplasma Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Mycoplasma Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Mycoplasma Diagnostics, Product and Application

Table 22. Global Key Players of Mycoplasma Diagnostics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Mycoplasma Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Mycoplasma Diagnostics Revenue Market Share by Type (2020-2025)

Table 26. Global Mycoplasma Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Mycoplasma Diagnostics Revenue Market Share by Type (2026-2031)

Table 28. Global Mycoplasma Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Mycoplasma Diagnostics Revenue Market Share by Application (2020-2025)

Table 30. Global Mycoplasma Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Mycoplasma Diagnostics Revenue Market Share by Application (2026-2031)

Table 32. North America Mycoplasma Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Mycoplasma Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Mycoplasma Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Mycoplasma Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Mycoplasma Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Mycoplasma Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Mycoplasma Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Mycoplasma Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Mycoplasma Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Mycoplasma Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Mycoplasma Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Agilent Technologies Company Details

Table 48. Agilent Technologies Business Overview

Table 49. Agilent Technologies Mycoplasma Diagnostics Product

Table 50. Agilent Technologies Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 51. Agilent Technologies Recent Development

Table 52. Thermo Fisher Scientific Company Details

Table 53. Thermo Fisher Scientific Business Overview

Table 54. Thermo Fisher Scientific Mycoplasma Diagnostics Product

Table 55. Thermo Fisher Scientific Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Scientific Recent Development

Table 57. PromoCell Company Details

Table 58. PromoCell Business Overview

Table 59. PromoCell Mycoplasma Diagnostics Product

Table 60. PromoCell Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 61. PromoCell Recent Development

Table 62. Charles River Laboratories International Company Details

Table 63. Charles River Laboratories International Business Overview

Table 64. Charles River Laboratories International Mycoplasma Diagnostics Product

Table 65. Charles River Laboratories International Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 66. Charles River Laboratories International Recent Development

Table 67. Merck KGaA Company Details

Table 68. Merck KGaA Business Overview

Table 69. Merck KGaA Mycoplasma Diagnostics Product

Table 70. Merck KGaA Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 71. Merck KGaA Recent Development

Table 72. Lonza Group Company Details

Table 73. Lonza Group Business Overview

Table 74. Lonza Group Mycoplasma Diagnostics Product

Table 75. Lonza Group Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Lonza Group Recent Development

Table 77. Takara Bio (Takara Holding Company.) Company Details

Table 78. Takara Bio (Takara Holding Company.) Business Overview

Table 79. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product

Table 80. Takara Bio (Takara Holding Company.) Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 81. Takara Bio (Takara Holding Company.) Recent Development

Table 82. Savyon Diagnostics Company Details

Table 83. Savyon Diagnostics Business Overview

Table 84. Savyon Diagnostics Mycoplasma Diagnostics Product

Table 85. Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 86. Savyon Diagnostics Recent Development

Table 87. Tecan Trading (Tecan Group) Company Details

Table 88. Tecan Trading (Tecan Group) Business Overview

Table 89. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product

Table 90. Tecan Trading (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 91. Tecan Trading (Tecan Group) Recent Development

Table 92. Sartorius Stedim BioOutsource Company Details

Table 93. Sartorius Stedim BioOutsource Business Overview

Table 94. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product

Table 95. Sartorius Stedim BioOutsource Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 96. Sartorius Stedim BioOutsource Recent Development

Table 97. American Type Culture Collection (ATCC) Company Details

Table 98. American Type Culture Collection (ATCC) Business Overview

Table 99. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product

Table 100. American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 101. American Type Culture Collection (ATCC) Recent Development

Table 102. F Hoffmann-La Roche Company Details

Table 103. F Hoffmann-La Roche Business Overview

Table 104. F Hoffmann-La Roche Mycoplasma Diagnostics Product

Table 105. F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2020-2025) & (US$ Million)

Table 106. F Hoffmann-La Roche Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Mycoplasma Diagnostics Picture

Figure 2. Global Mycoplasma Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Mycoplasma Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Kits & Reagents Features

Figure 5. Instruments Features

Figure 6. Software & Services Features

Figure 7. Global Mycoplasma Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Mycoplasma Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Clinics Case Studies

Figure 12. Others Case Studies

Figure 13. Mycoplasma Diagnostics Report Years Considered

Figure 14. Global Mycoplasma Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Mycoplasma Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Mycoplasma Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Mycoplasma Diagnostics Market Share by Players in 2024

Figure 18. Global Top Mycoplasma Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Diagnostics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Mycoplasma Diagnostics Revenue in 2024

Figure 20. North America Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Mycoplasma Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Mycoplasma Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Mycoplasma Diagnostics Market Share by Region (2020-2031)

Figure 34. China Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Mycoplasma Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Mycoplasma Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Mycoplasma Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Agilent Technologies Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 51. PromoCell Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 52. Charles River Laboratories International Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 53. Merck KGaA Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 54. Lonza Group Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 55. Takara Bio (Takara Holding Company.) Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 56. Savyon Diagnostics Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 57. Tecan Trading (Tecan Group) Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 58. Sartorius Stedim BioOutsource Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 59. American Type Culture Collection (ATCC) Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 60. F Hoffmann-La Roche Revenue Growth Rate in Mycoplasma Diagnostics Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19E17259

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39U17029

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-24Y16719

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0S20450

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Mycoplasma Diagnostics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-36E5970

Global Mycoplasma Diagnostics Market Research Report 2025

FEATURED COMPANIES

Mycoplasma Diagnostics Market Size

Mycoplasma Diagnostics Market

Scope of Mycoplasma Diagnostics Market Report

Chapter Outline

FAQ for this report

How fast is Mycoplasma Diagnostics Market growing?

What is the Mycoplasma Diagnostics Market size in 2031?

Who are the main players in the Mycoplasma Diagnostics Market report?

What are the Application segmentation covered in the Mycoplasma Diagnostics Market report?

What are the Type segmentation covered in the Mycoplasma Diagnostics Market report?

FEATURED COMPANIES

RELATED REPORTS